Ofloxacine Stulln

Quick links

Choose a section

Quick links to important sections

Advertisements
Advertisements

Overview of Ofloxacine Stulln

What is Ofloxacine Stulln: Definition and Classification

Property Description
Active Ingredient Ofloxacin
Form Otic Solution (Ear Drops)
Pharmacological Class Fluoroquinolone Antibiotic
Common Use Combating bacterial infections
Origin Synthetic

Ofloxacine Stulln is a pharmaceutical preparation that functions as an antimicrobial drug, intended for the localized management of bacterial presence. Its therapeutic effect is provided by the single active substance, Ofloxacin, which is a chemically synthetic compound derived from the quinolone structure. Ofloxacin is classified as a fluoroquinolone antibiotic, a drug group characterized by its action against bacterial life. As a second-generation agent in this class, Ofloxacin possesses broad-spectrum capability, making it effective against various Gram-negative and Gram-positive bacteria. Fluoroquinolones like Ofloxacin work by eliminating susceptible organisms through the disruption of vital bacterial enzymes.


Form and Purpose: An Otic Solution

Ofloxacine Stulln is formulated as an otic solution, meaning it is presented as ear drops in an aqueous vehicle for direct administration into the ear canal. This preparation is typically dispensed in a unit dose format, a feature that supports single-use application and is intended to facilitate patient compliance. The primary purpose of this formulation is to deliver the bactericidal effect of Ofloxacin directly to the site of infection within the ear. By concentrating the antibiotic at the necessary area, the localized treatment aims to eliminate the pathogenic bacteria responsible for the infection while minimizing systemic exposure. This localized approach is used for external ear infections, focusing the drug where the bacterial activity is present.

Regulatory References

  1. NIH StatPearls: Ofloxacin
Advertisements

What side effects are possible with Ofloxacine Stulln?

Possible side effects and safety information

The safety profile for Ofloxacin otic solution is formally documented by regulatory authorities, classifying possible effects by frequency and system involvement. As an otic solution, the most common effects are generally localized to the site of administration.

Frequency Classification and System Involvement

Adverse reactions are grouped according to the physiological system affected and their reported incidence in clinical data:

Classification System-Organ Class Examples Documented Effects
Common Ear and Labyrinth, Nervous System, Gastrointestinal Pruritus (ear), application site reaction, taste perversion, dizziness, headache
Uncommon Ear and Labyrinth, Nervous System Earache, tinnitus, paresthesia, transient hearing loss

Serious Adverse Reactions and Class Effects

The official labeling documents serious safety considerations associated with the fluoroquinolone class to which Ofloxacin belongs, even though the otic route has low systemic absorption. These documented serious risks include tendinitis and tendon rupture and the potential for severe hypersensitivity reactions (e.g., anaphylaxis). The medicine is strictly contraindicated in patients with a history of hypersensitivity to Ofloxacin or any other quinolone antibiotic.

Specific Safety Constraints

For administration, regulatory information notes that instilling a cold solution into the ear may cause dizziness. Additionally, as with other anti-infectives, prolonged use may lead to the overgrowth of non-susceptible organisms, including fungi. Safety is established for use in paediatric patients for specific indications from six months of age. For pregnant or nursing patients, a formal safety review is required to determine whether to discontinue the drug or discontinue nursing.

Advertisements

Overdose and Emergency Response

Overdose and when to seek help

Official regulatory information for Ofloxacin establishes the profile for acute overdosage, primarily considering the potential for systemic toxicity following accidental ingestion of the otic solution. Although the local application carries a low risk of systemic effects, ingestion can expose the body to high concentrations of the active substance.

Documented Overdose Manifestations

Acute systemic overexposure is officially documented to cause manifestations related to the Central Nervous System (CNS) and Gastrointestinal System. Documented CNS effects include drowsiness, dizziness, confusion, lightheadedness, and tremors. Gastrointestinal presentations include nausea and severe stomach pain.

Required Emergency Actions

The FDA and other regulatory agencies mandate that emergency medical attention must be sought immediately if Ofloxacine Stulln is accidentally swallowed or if any severe symptoms develop. Specific, regulator-mandated actions include calling the Poison Help line or local emergency services if the person has collapsed or is not breathing. The documented severe outcomes include convulsions (seizures), toxic psychosis, and prolongation of the QT interval.

Management and Antidote

Management of acute overdose is restricted to symptomatic and supportive treatment. Official labeling states that no specific antidote is known. Additionally, regulatory documents note that patients with severe cerebral arteriosclerosis or epilepsy may have an increased risk for convulsions following systemic exposure.

Advertisements

Therapeutic Uses of Ofloxacine Stulln

What Ofloxacine Stulln treats: main uses and benefits

Ofloxacine Stulln is an antibacterial medication designed for ophthalmic use. It contains ofloxacin, a fluoroquinolone antibiotic that works by interfering with the ability of bacteria to replicate their DNA, thereby stopping the growth of the infection.

Primary Indications

This medication is primarily used to treat external bacterial infections of the eye. It is effective against a broad spectrum of gram-positive and gram-negative bacteria that commonly affect the ocular surface and surrounding structures.

  • Bacterial Conjunctivitis: This is an infection of the conjunctiva, the thin membrane covering the white part of the eye and the inner surface of the eyelids. It is often characterized by redness, discharge, and irritation.
  • Bacterial Corneal Ulcers: This is a more serious infection affecting the cornea, the clear front surface of the eye. Prompt treatment is necessary to protect visual clarity and structural integrity of the eye.

Scope of Activity

Ofloxacin is a potent antimicrobial agent. Its primary benefits in clinical use include:

  • Broad-Spectrum Efficacy: It is active against various organisms, including Staphylococcus aureus, Streptococcus pneumoniae, and Pseudomonas aeruginosa.
  • Rapid Action: As a bactericidal agent, it works quickly to eliminate the causative pathogens of the infection.
  • Targeted Treatment: Because it is applied locally as eye drops, the medication reaches high concentrations at the site of infection with minimal systemic absorption.

Limitations of Use

It is important to note that Ofloxacine Stulln is specifically formulated for bacterial infections. It is not effective against infections caused by viruses (such as the common cold or viral conjunctivitis), fungi, or parasites. Using antibiotics when they are not needed increases the risk of developing antibiotic-resistant infections in the future.

Advertisements

Eligibility and Restrictions for Use

The use of Ofloxacine Stulln (Ofloxacin otic solution) is strictly governed by population eligibility rules outlined in official regulatory documents. Eligibility is defined by absolute contraindications, age limits, and physiological status.

Contraindications and Non-Eligibility

Classification Population/Condition
Absolutely Contraindicated History of hypersensitivity to ofloxacin, to other quinolones, or to any component of the medication.
Conditional Use Pregnancy: Use only if the potential benefit justifies the potential risk to the fetus.
Not Recommended Lactation/Breastfeeding: A decision to discontinue nursing or discontinue the drug must be made.

Age-Related Eligibility

The medicine is approved for adults. In pediatric patients, eligibility is determined by age and the specific ear infection treated. Safety and efficacy have not been established in infants below the lowest approved age threshold, which may be six months (for Otitis Externa) or one year (for Acute Otitis Media with Tympanostomy Tubes). For chronic suppurative otitis media with a perforated eardrum, use is restricted to patients 12 years and older.

Other Restrictions

Due to minimal systemic absorption, official labeling generally does not impose specific restrictions based on renal or hepatic impairment for the otic solution.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

Co-administration of Ofloxacin with certain other medicines or substances can lead to changes in drug levels, increased risk of adverse effects, or reduced absorption.

Substances Affecting Ofloxacin Levels

Substance Category Interaction Mechanism Practical Requirement
Metal Cations (e.g., Iron, Antacids, Sucralfate) Chelation reduces Ofloxacin absorption. Time Separation: Do not take within 2 hours before or 2 hours after Ofloxacin.
Renal Inhibitors (e.g., Probenecid) Reduces Ofloxacin clearance in the kidney. Monitoring: Potential increase in Ofloxacin plasma levels requires close observation.

Pharmacodynamic Interactions (Additive Risk)

Combining Ofloxacin with the following drug classes increases the risk of specific adverse effects:

  • QT-Prolonging Drugs: Co-administration with agents like Class IA and Class III antiarrhythmics increases the risk of cardiac rhythm disorders (QTc prolongation).
  • Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): Use with certain NSAIDs, such as Fenbufen, increases the risk of Central Nervous System (CNS) toxicity and convulsions.
  • Oral Hypoglycemic Agents (e.g., Glibenclamide): Increased risk of hypoglycemia is documented, requiring strict blood glucose monitoring.
  • Vitamin K Antagonists (e.g., Warfarin): Co-administration may affect coagulation parameters, necessitating monitoring of INR/PT to manage bleeding risk.
Advertisements

Mechanism of Action

How Ofloxacine Stulln Works

Ofloxacine Stulln acts as an inhibitor by targeting two essential enzymes within susceptible bacterial cells: DNA gyrase and Topoisomerase IV. These bacterial enzymes are critical for managing the coiling and structure of the microbe's DNA, a necessary step for replication, transcription, and repair. The medication binds to the enzyme-DNA complex, stabilizing the cleaved DNA strands and preventing their re-ligation.

This molecular interaction causes the accumulation of widespread, irreversible double-strand breaks in the bacterial genome. The resulting overwhelming genetic damage triggers an internal cascade of self-destruction (apoptosis-like process) within the cell. This mechanistic sequence leads to the bactericidal effect, resulting in the rapid termination of microbial cell viability and the physical clearance of the targeted foreign cells.

Advertisements

Dosage and Administration Information

Administration Overview

Ofloxacine Stulln is intended for topical application to the eye. Proper administration technique is important to maintain the sterility of the solution and to ensure the medication is applied effectively.

Application Procedure

To apply the eye drops, the head is typically tilted back slightly while the lower eyelid is gently pulled down to create a small pocket. The prescribed number of drops is then placed into this conjunctival sac. During this process, it is important to avoid contact between the dropper tip and the eye, eyelids, or any other surfaces to prevent contamination of the bottle contents.

After application, closing the eye and applying gentle pressure to the tear duct (the inner corner of the eye) for a brief period can help keep the medication in contact with the eye surface and reduce systemic absorption.

Usage with Other Ophthalmic Products

If more than one type of eye medication is being used, it is standard practice to wait a specific interval between the applications of different products. This prevents the first medication from being washed out by the second and ensures both are absorbed correctly. Typically, eye drops are applied before eye ointments.

Contact Lens Considerations

In general, wearing contact lenses is not recommended during the treatment of an eye infection. Furthermore, certain components in the eye drop solution may interact with contact lens materials. If lens wear is necessary, lenses should be removed prior to application and should not be reinserted until a sufficient amount of time has passed following the dose.

Advertisements

Recent Clinical Evidence

Research Evidence / Overview of Studies for Ofloxacine Stulln

The research base for Ofloxacin Otic Solution is centered on short-term clinical trials examining three specific types of ear infections. The evidence focuses exclusively on describing the measured patterns observed during the study periods, rather than providing individual predictions or therapeutic recommendations.


Evidence for Use in Acute Otitis Externa (AOE)

Short-term Randomized Controlled Trials (RCTs) have been conducted in both adults and pediatric patients (as young as six months). Researchers evaluated measurements of change in visible signs of infection and whether rates of microbiological clearance were observed. Research describes group patterns but is limited regarding long-term status and recurrence patterns.

Evidence for Use in Acute Otitis Media with Tympanostomy Tubes

The clinical study data primarily involves short-term RCTs in pediatric populations (age one year and older) with ventilation tubes. The studies focused on monitoring the measured cessation of drainage (otorrhea) and were often evaluated against different types of comparator treatments. A major limitation is that the results apply only to children with tubes, and follow-up durations are limited.

Evidence for Use in Chronic Suppurative Otitis Media (CSOM)

Research for adolescents and adults (age 12 and older) with chronic drainage includes Systematic Reviews and RCTs. These studies explored measurements related to physical discomfort and chronic ear discharge. The Systematic Reviews describe the measured rates of change, though the evidence quality varies across the individual aggregated studies.


Research Gaps and Areas of Uncertainty

The research base concentrates heavily on immediate and short-term outcomes (up to approximately four weeks). Consequently, long-term effects are not fully established, and data offering insight into the persistence of observed effects beyond six months are often limited. Furthermore, data for certain groups remain insufficient, including those with certain comorbidities, and research summaries currently contain limited data related to pregnant or breastfeeding populations.

Key Studies & References

  1. A systematic review of the effectiveness of ofloxaxin otic solution for the treatment of suppurative otitis media
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Ofloxacine Stulln (FAQ)

Q: Do I need to avoid sunlight while using Ofloxacine Stulln?

A: The drug class to which Ofloxacin belongs (fluoroquinolones) is generally associated with photosensitivity (increased skin sensitivity to sun exposure). While the ear drop formulation has low absorption, official advice for the systemic form includes taking precautions. These may include using protective clothing or seeking shade when exposed to sunlight.

Q: Can Ofloxacine Stulln affect my ability to drive or use machinery?

A: Official documents state that side effects like dizziness and headache are possible with this medicine. If these effects occur, official information indicates that caution is appropriate regarding driving or operating machinery.

Q: Can Ofloxacine Stulln affect a heart condition?

A: Regulatory documents mention a class-related precaution regarding the potential for a change in heart rhythm called QTc prolongation. Regulatory precautions regarding this risk are specifically noted when the drug is combined with other specific heart medications or used systemically.

Q: Does Ofloxacine Stulln have an effect on sleep?

A: Regulatory documents list a range of Central Nervous System (CNS) effects that can occur with quinolones. These include side effects like dizziness and, less commonly, paresthesia (a tingling sensation). Insomnia (difficulty sleeping) is also noted as a side effect for the oral form of Ofloxacin.

Q: Is the safety profile of Ofloxacine Stulln well-studied?

A: The safety profile for Ofloxacin otic solution is described in regulatory documents and is based on short-term clinical trials. Studies have primarily focused on immediate outcomes, often measured up to approximately four weeks. Consequently, official information indicates that data on effects beyond the short-term study periods are generally limited.

Q: Is Ofloxacine Stulln typically used for short or long-term courses?

A: According to official dosing schedules, Ofloxacine Stulln (otic solution) is designed for short-term courses of therapy. The official dosing schedules describe treatment as short-term, typically lasting between 7 and 14 days, depending on the specific condition.

Q: Are there specific warnings I should be aware of regarding Ofloxacine Stulln?

A: Official warnings cover several serious safety considerations. These include the potential for tendinitis and tendon rupture associated with the drug class, the risk of severe allergic reactions, and the possibility of overgrowth of other organisms if the drops are used for too long. These warnings are noted in the official documents due to the nature of the drug class, even with the localized ear drop formulation.

Q: Is Ofloxacine Stulln the same as other medicines that treat similar conditions?

A: Ofloxacine Stulln contains the active ingredient Ofloxacin, which is classified as a specific type of fluoroquinolone antibiotic. While other medicines may treat similar ear infections, they may contain different active ingredients or belong to different drug classes with varying mechanisms of action.

Q: Can Ofloxacine Stulln be used for conditions other than those listed in the official uses?

A: Official drug documents only describe and confirm the use of Ofloxacine Stulln for specific, labeled ear infections. Information on use for conditions outside these indications is not provided in official documentation.

Q: How long does it usually take for Ofloxacine Stulln to start working?

A: Research evidence focuses on measurable change, noting that initial changes in outcomes like reduction of discharge typically begin to be observed within the first few days of the prescribed course.

Q: Can Ofloxacine Stulln cause headache or dizziness?

A: Yes, official regulatory documents classify both headache and dizziness as common side effects that were observed in clinical data for the otic solution. These effects are usually mild and related to the drug's action.

Q: Are there any serious but rare side effects associated with Ofloxacine Stulln?

A: Official labeling documents the potential for serious risks associated with the drug class. These include the risk of tendinitis and tendon rupture and severe allergic reactions (like anaphylaxis). These are important safety considerations, even if they occur very infrequently.

Q: Is it true that Ofloxacine Stulln can interact with dairy products?

A: The oral form of Ofloxacin is known to interact with metal cations, including the calcium found in dairy products, which can reduce the drug's absorption into the body. Though absorption is minimal with ear drops, general interaction precautions are noted in official information.

Q: What kinds of medicines are known to interact with Ofloxacine Stulln?

A: Official documents describe interactions with several drug types, including medications that affect heart rhythm (QT-Prolonging Drugs), some types of NSAIDs, medicines for blood sugar (Oral Hypoglycemic Agents), and blood thinners (Vitamin K Antagonists).

Q: Is Ofloxacine Stulln safe for children?

A: Official documentation states that safety and efficacy have been established for pediatric patients for specific uses, with the lowest approved threshold being six months for Otitis Externa.

Q: What is known about using Ofloxacine Stulln during pregnancy?

A: Official labeling places the use of Ofloxacine Stulln during pregnancy under a Conditional Use status. This means that official documents require the potential benefit to justify the potential risk to the fetus.

Q: Can I use Ofloxacine Stulln while breastfeeding?

A: Official documentation states that a decision regarding treatment requires careful consideration as to whether to discontinue nursing or discontinue the drug, as data in this population are limited.

Q: Where can I find the official package leaflet for Ofloxacine Stulln?

A: Official drug information, often called the package leaflet or Summary of Product Characteristics (SmPC), is publicly accessible. This information is available through government drug agency websites, such as DailyMed (FDA) or the EMA database, and is also provided with the product at the pharmacy.

Q: What is the difference between Ofloxacine Stulln and the generic version?

A: Ofloxacine Stulln is the specific brand name for this medication. The generic version contains the identical active ingredient, which is Ofloxacin. Both brand and generic products function as an antimicrobial drug in the same way, according to regulatory standards.

Q: Why does the official document mention a risk of tendon issues with Ofloxacine Stulln?

A: The risk of tendinitis and tendon rupture is mentioned because Ofloxacin belongs to the entire fluoroquinolone class of antibiotics. This serious adverse reaction has been documented as a class effect of these medicines, necessitating a warning even for the localized ear drop formulation.

Q: Can Ofloxacine Stulln affect my blood sugar levels?

A: The drug class is associated with a potential risk of hypoglycemia (low blood sugar) when the oral form is combined with certain other medicines for managing blood sugar. Regulatory documents note that close monitoring of blood glucose is appropriate for this specific combination.

Q: Does Ofloxacine Stulln interact with over-the-counter pain relievers?

A: Regulatory documents explicitly mention interactions with certain Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), such as Fenbufen, which can increase the risk of Central Nervous System toxicity. Some common over-the-counter pain relievers belong to the NSAID class.

Q: Why do some people report changes in taste with Ofloxacine Stulln?

A: Official documents list taste perversion (altered taste) as a common side effect of the ear drops. This is believed to occur because the ear canal is connected to the back of the throat through the Eustachian tube, allowing trace amounts of the medicine to reach the mouth, resulting in a temporary bitter or metallic taste.

Q: Can Ofloxacine Stulln interact with medicines for acid reflux?

A: Yes, Ofloxacin is known to interact with medicines that contain metal cations, such as certain antacids used for acid reflux. These products can reduce the absorption of the drug, and official documents often advise separating the dosing times.

Q: Are there specific risk groups mentioned in official documents for Ofloxacine Stulln?

A: Yes, official documents specify risk groups for whom use is strictly forbidden, such as those with a history of quinolone hypersensitivity. Precautions are also noted for patients taking specific QT-prolonging drugs or certain NSAIDs.

Q: Does Ofloxacine Stulln require a prescription?

A: Yes, Ofloxacine Stulln (Ofloxacin otic solution) is officially classified as a prescription-only medication (Rx Only) in nearly all regulatory jurisdictions.

Q: Are there any specific dietary needs when taking Ofloxacine Stulln?

A: Official warnings primarily involve the need to separate dosing from any products or supplements that contain metal cations (like calcium, iron, or zinc). This separation is typically advised to prevent these substances from reducing the drug's systemic absorption.

Advertisements

How should Ofloxacine Stulln be stored and disposed of?

Storage and Disposal of Ofloxacine Stulln

Ofloxacine Stulln ear drops must be stored strictly according to labeled requirements to maintain stability. The product must not be stored above 25°C and it is forbidden to refrigerate or freeze the medicine. To ensure protection from light, the product must remain in the original package.

Stability and Container

The labeled stability for the unopened product is 24 months. However, once the aluminum pouches containing the unit-dose containers are opened, the in-use shelf life is limited to four weeks.

Disposal Rules

All medicine must be kept out of the reach of children and pets. Unused or expired medication must be thrown away according to guidance from a healthcare professional; disposal by flushing down a toilet or drain is not permitted unless specifically instructed.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Ofloxacine Stulln found in:

A-Z Index: